Our partners

KHP Ventures is a collaboration between:

• King's College London
• King's College Hospital NHS Foundation Trust
• Guy's and St Thomas' Hospital NHS Foundation Trust

They offer equity investments with healthcare expertise for ground-breaking MedTech and digital start-ups.

The King's Technology Evaluation Centre (KiTEC) is a collaboration between:

• several King's College London departments
• the medical physics department at Guy's and St Thomas' NHS Foundation Trust

KiTEC provides a health technology assessment (HTA) service for a variety of public and private sector clients. This includes Medical Technologies Evaluation Programme (MTEP) and Diagnostics Assessment Programme (DAP) project work for NICE.

KiTEC is currently performing the function of independent evaluator for the NHS Transformation Directorate Accelerated Access Collaboration NIHR AI awards.

The London Medical Imaging and AI Centre for Value Based Healthcare trains sophisticated artificial intelligence algorithms from NHS medical images and patient data. This provides tools for clinicians to speed up and improve diagnosis and care across several patient pathways including:

• stroke
• dementia
• heart failure
• cancer

Clinical Scientific Computing (CSC) at Guy's and St Thomas' is a core member of the London Medical Imaging and AI Centre for Value-Based Healthcare.

Working with a number of computer engineers and programmers allows access to the world's largest supercomputer dedicated to healthcare (Cambridge-1). It also means being an integral part of the AI product lifecycle from research and development, to procurement and post-market analysis.

The clinical engineering team at Guy's and St Thomas' supports the improvement of patient care through the use of technology.

This includes:

• speeding up the safe and efficient introduction of new medical technologies worth over £10 million every year
• developing home grown devices to support diagnostics, procedures and patient discharge

The King’s Health Partners Cancer Biobank is fundamental to our aim, as a Comprehensive Cancer Centre, of bringing together our world class research, teaching and clinical practice for the benefit of patients.

We have a well-established tradition of biobanking with a long history of tissue and data use across the UK and Europe. We are constantly improving our resources by collecting a more diverse range of sample types from the majority of cancers. The Biobank resources are essential in understanding what causes cancer, which treatment options are likely to be effective and how to improve patient care in the years to come.

Our aim is to collect tissue and blood samples from patients who attend Guy's and St Thomas' hospitals and who have a diagnosis or possible diagnosis of cancer.

We also collect some samples from patients without cancer and also from healthy volunteers.